# APOA4

## Overview
The APOA4 gene encodes apolipoprotein A-IV (apoA-IV), a protein primarily synthesized in the small intestine and involved in lipid metabolism and cardiovascular health. As a member of the apolipoprotein family, apoA-IV is characterized by its elongated helical structure and is the largest among exchangeable apolipoproteins. It plays a crucial role in regulating lipoprotein metabolism, reverse cholesterol transport, and exhibits anti-oxidation and anti-inflammatory properties. ApoA-IV circulates in the plasma both in lipid-free form and associated with lipoprotein particles, such as high-density lipoproteins (HDL) and chylomicrons. The expression of APOA4 is influenced by dietary fat intake, linking it to broader metabolic processes. Mutations in the APOA4 gene have been associated with various health conditions, including cardiovascular diseases, depression, and Alzheimer's disease, highlighting its clinical significance (Wang2012Apolipoprotein; Lin2015Decreased; Xu2018Apolipoprotein).

## Structure
Apolipoprotein A-IV (apoA-IV) is characterized by its elongated helical structure, which dimerizes through two long reciprocating helices. The primary structure includes conserved proline residues spaced approximately 22 amino acids apart, which play a significant role in the protein's structural and functional properties by disrupting the hydrogen-bonding pattern of helices, leading to segmentation and potential curvature in the secondary structure (Deng2015Role). The tertiary structure involves a large helical bundle domain, and the quaternary structure is characterized by a 'helix swap' mechanism, where one helix from one chain integrates with three helices from another chain to form tandem, head-to-tail four-helix bundle motifs (Deng2015Role).

ApoA-IV is the largest among exchangeable apolipoproteins, with 376 amino acids dominated by 22-amino acid repeats forming amphipathic alpha helices (Walker2014The). These repeats are clustered between residues 40 and 332, with a unique glutamine-rich sequence at the C-terminus (Walker2014The). The protein's structure is sensitive to environmental changes such as pH and the presence of guanidine hydrochloride, which can affect its stability and lipid binding properties (Weinberg1985Structural). The protein is predominantly of intestinal origin and is found on nascent mesenteric chylomicrons in lymph, but it rapidly dissociates upon entering circulation (Weinberg1985Structural).

## Function
Apolipoprotein A-IV (apoA-IV) is a multifunctional protein primarily synthesized in the small intestine and plays a significant role in lipid metabolism and cardiovascular health. It is involved in the regulation of lipoprotein metabolism, reverse cholesterol transport, and has anti-oxidation and anti-inflammatory properties (Xu2018Apolipoprotein). ApoA-IV is known to bind to the αIIbβ3 integrin on platelets, inhibiting platelet aggregation and thrombosis, which suggests its role as an endogenous protective factor against cardiovascular diseases (Xu2018Apolipoprotein).

In addition to its cardiovascular functions, apoA-IV enhances glucose-induced insulin secretion, particularly under high glucose conditions, thereby contributing to glucose homeostasis and potentially serving as a therapeutic target for type 2 diabetes mellitus (Wang2012Apolipoprotein). ApoA-IV also promotes cholesterol efflux from adipose cells, indicating its role in cholesterol metabolism and cellular cholesterol homeostasis (Steinmetz1990Human).

ApoA-IV is active in the plasma, where it circulates in both lipid-free form and associated with lipoprotein particles, such as high-density lipoproteins (HDL) and chylomicrons (Xu2018Apolipoprotein). Its expression is regulated by dietary fat intake, linking intestinal lipid absorption to broader metabolic processes (Wang2012Apolipoprotein).

## Clinical Significance
Mutations and alterations in the APOA4 gene have been linked to several diseases and conditions. The Gln360His polymorphism in APOA4 is associated with an increased risk of depression and an unfavorable lipid profile, characterized by elevated triglyceride and very low-density lipoprotein (VLDL) levels, along with reduced high-density lipoprotein (HDL) levels. Carriers of the 360His allele have a two-fold increased risk for depression and obesity (Ota2011APOA4).

Decreased expression of the APOA1-APOC3-APOA4 gene cluster, including APOA4, has been associated with Alzheimer's disease (AD). Lower mRNA and protein levels of APOA4 are observed in AD patients, correlating with increased severity of cognitive impairment and depression (Lin2015Decreased).

The APOA4 gene also plays a role in cardiovascular health. A rare variant, Val336Met, has been identified in individuals with low HDL cholesterol levels and coronary artery disease (CAD). This mutation affects the protein's lipid-binding capacity, potentially contributing to HDL dysfunction and increased CAD risk (Chroni2020Identification).

APOA4 is also implicated in inflammatory conditions. Reduced levels of ApoA-IV, the protein encoded by APOA4, are associated with allergic conditions and chronic rhinosinusitis, suggesting its role as an anti-inflammatory agent (Roula2019Apolipoprotein).

## Interactions
Apolipoprotein A4 (APOA4) is involved in various protein interactions that influence lipid and glucose metabolism. APOA4 interacts with nuclear receptors NR1D1 (Rev-erbα) and NR4A1, which are involved in the suppression of hepatic gluconeogenesis. In human HepG2 cells, APOA4 binds to the RORα response element (RORE) of the human G6Pase promoter region, leading to transcriptional repression and downregulation of gluconeogenic genes (Qu2019Apolipoprotein).

APOA4 also interacts with low-density lipoprotein receptor-related protein 1 (LRP1) in adipose tissue. This interaction is enhanced by lipid feeding and is crucial for APOA4-stimulated glucose uptake in adipocytes, functioning in an insulin-independent manner. LRP1 serves as a receptor for APOA4, facilitating glucose uptake and activating AKT signaling pathways (Qu2021Lowdensity).

In the context of cholesterol metabolism, APOA4 binds to receptor sites that also recognize apolipoproteins A-I and A-II, promoting cholesterol efflux from adipose cells. This interaction is demonstrated by competition experiments showing that APOA4 shares common binding sites with these apolipoproteins (Steinmetz1990Human). These interactions highlight APOA4's role in lipid transport and metabolic regulation.


## References


[1. (Deng2015Role) Xiaodi Deng, Ryan G. Walker, Jamie Morris, W. Sean Davidson, and Thomas B. Thompson. Role of conserved proline residues in human apolipoprotein a-iv structure and function. Journal of Biological Chemistry, 290(17):10689–10702, April 2015. URL: http://dx.doi.org/10.1074/jbc.m115.637058, doi:10.1074/jbc.m115.637058. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m115.637058)

[2. (Qu2019Apolipoprotein) Jie Qu, Chih-Wei Ko, Patrick Tso, and Aditi Bhargava. Apolipoprotein a-iv: a multifunctional protein involved in protection against atherosclerosis and diabetes. Cells, 8(4):319, April 2019. URL: http://dx.doi.org/10.3390/cells8040319, doi:10.3390/cells8040319. This article has 109 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells8040319)

[3. (Ota2011APOA4) Vanessa Kiyomi Ota, Elizabeth Suchi Chen, Tatiana Flank Ejchel, Tatiane Katsue Furuya, Diego Robles Mazzotti, Maysa Seabra Cendoroglo, Luiz Roberto Ramos, Lara Quirino Araujo, Rommel Rodriguez Burbano, and Marília de Arruda Cardoso Smith. Apoa4 polymorphism as a risk factor for unfavorable lipid serum profile and depression: a cross-sectional study. Journal of Investigative Medicine, 59(6):966–970, August 2011. URL: http://dx.doi.org/10.2310/JIM.0b013e31822467cd, doi:10.2310/jim.0b013e31822467cd. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.2310/JIM.0b013e31822467cd)

[4. (Wang2012Apolipoprotein) Fei Wang, Alison B. Kohan, Tammy L. Kindel, Kathryn L. Corbin, Craig S. Nunemaker, Silvana Obici, Stephen C. Woods, W. Sean Davidson, and Patrick Tso. Apolipoprotein a-iv improves glucose homeostasis by enhancing insulin secretion. Proceedings of the National Academy of Sciences, 109(24):9641–9646, May 2012. URL: http://dx.doi.org/10.1073/pnas.1201433109, doi:10.1073/pnas.1201433109. This article has 98 citations.](https://doi.org/10.1073/pnas.1201433109)

[5. (Lin2015Decreased) Qiao Lin, Yunpeng Cao, and Jie Gao. Decreased expression of the apoa1&amp;ndash;apoc3&amp;ndash;apoa4 gene cluster is associated with risk of alzheimer&amp;rsquo;s disease. Drug Design, Development and Therapy, pages 5421, September 2015. URL: http://dx.doi.org/10.2147/DDDT.S89279, doi:10.2147/dddt.s89279. This article has 47 citations.](https://doi.org/10.2147/DDDT.S89279)

[6. (Qu2021Lowdensity) Jie Qu, Sarah Fourman, Maureen Fitzgerald, Min Liu, Supna Nair, Juan Oses-Prieto, Alma Burlingame, John H. Morris, W. Sean Davidson, Patrick Tso, and Aditi Bhargava. Low-density lipoprotein receptor-related protein 1 (lrp1) is a novel receptor for apolipoprotein a4 (apoa4) in adipose tissue. Scientific Reports, June 2021. URL: http://dx.doi.org/10.1038/s41598-021-92711-0, doi:10.1038/s41598-021-92711-0. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-92711-0)

[7. (Chroni2020Identification) Angeliki Chroni, Loukianos Rallidis, Despoina Vassou, Christina Gkolfinopoulou, Paraskevi Papakosta, Maria I. Zervou, George N. Goulielmos, Estela Kiouri, Danae Pappa, Elias Eliopoulos, and Dimitris Kardassis. Identification and characterization of a rare variant in apolipoprotein a-iv, p.(v336m), and evaluation of hdl functionality in a greek cohort with extreme hdl cholesterol levels. Archives of Biochemistry and Biophysics, 696:108655, December 2020. URL: http://dx.doi.org/10.1016/j.abb.2020.108655, doi:10.1016/j.abb.2020.108655. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.abb.2020.108655)

[8. (Weinberg1985Structural) R B Weinberg and M S Spector. Structural properties and lipid binding of human apolipoprotein a-iv. Journal of Biological Chemistry, 260(8):4914–4921, April 1985. URL: http://dx.doi.org/10.1016/s0021-9258(18)89159-1, doi:10.1016/s0021-9258(18)89159-1. This article has 66 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)89159-1)

[9. (Roula2019Apolipoprotein) David Roula, Anna Theiler, Petra Luschnig, Gunter J. Sturm, Peter V. Tomazic, Gunther Marsche, Akos Heinemann, and Eva M. Sturm. Apolipoprotein a‐iv acts as an endogenous anti‐inflammatory protein and is reduced in treatment‐naïve allergic patients and allergen‐challenged mice. Allergy, 75(2):392–402, September 2019. URL: http://dx.doi.org/10.1111/all.14022, doi:10.1111/all.14022. This article has 27 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1111/all.14022)

[10. (Steinmetz1990Human) A Steinmetz, R Barbaras, N Ghalim, V Clavey, J C Fruchart, and G Ailhaud. Human apolipoprotein a-iv binds to apolipoprotein a-i/a-ii receptor sites and promotes cholesterol efflux from adipose cells. Journal of Biological Chemistry, 265(14):7859–7863, June 1990. URL: http://dx.doi.org/10.1016/s0021-9258(19)39010-6, doi:10.1016/s0021-9258(19)39010-6. This article has 175 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(19)39010-6)

[11. (Walker2014The) Ryan G. Walker, Xiaodi Deng, John T. Melchior, Jamie Morris, Patrick Tso, Martin K. Jones, Jere P. Segrest, Thomas B. Thompson, and W. Sean Davidson. The structure of human apolipoprotein a-iv as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering. Journal of Biological Chemistry, 289(9):5596–5608, February 2014. URL: http://dx.doi.org/10.1074/jbc.M113.541037, doi:10.1074/jbc.m113.541037. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M113.541037)

[12. (Xu2018Apolipoprotein) Xiaohong Ruby Xu, Yiming Wang, Reheman Adili, Lining Ju, Christopher M. Spring, Joseph Wuxun Jin, Hong Yang, Miguel A. D. Neves, Pingguo Chen, Yan Yang, Xi Lei, Yunfeng Chen, Reid C. Gallant, Miao Xu, Hailong Zhang, Jina Song, Peifeng Ke, Dan Zhang, Naadiya Carrim, Si-Yang Yu, Guangheng Zhu, Yi-Min She, Terry Cyr, Wenbin Fu, Guoqing Liu, Philip W. Connelly, Margaret L. Rand, Khosrow Adeli, John Freedman, Jeffrey E. Lee, Patrick Tso, Patrizia Marchese, W. Sean Davidson, Shaun P. Jackson, Cheng Zhu, Zaverio M. Ruggeri, and Heyu Ni. Apolipoprotein a-iv binds αiibβ3 integrin and inhibits thrombosis. Nature Communications, September 2018. URL: http://dx.doi.org/10.1038/s41467-018-05806-0, doi:10.1038/s41467-018-05806-0. This article has 74 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-05806-0)